Moderna beat on its top and bottom lines, reporting earnings per share of $11.29 and revenue of $7.2 billion.

The company raised its 2022 guidance for Covid vaccine sales by $2 billion.

CEO Stephane Bancel told CNBC the world may be moving out of the pandemic and into an endemic phase as the omicron wave subsides in the U.S. and around the world.